Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.40 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.39 |
| ▸ | P2RY12 | Q9H244 | 3/20 | 0.38 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.38 |
| ▸ | AHCY | P23526 | 2/20 | 0.37 |
| ▸ | PDE2A | O00408 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9689744 | 0.87 | ADORA3 (0.59) | ADORA3ADORA2ASLC29A1 | |
| SCHEMBL9689114 | 0.81 | ADORA2A (0.36) | ADORA3ADORA2A | |
| SCHEMBL9689709 | 0.78 | ABCB1 (0.38) | ADORA3ADORA2ASLC29A1 | |
| SCHEMBL9687934 | 0.74 | SLC29A1 (0.43) | ADORA3ADORA2ASLC29A1P2RY12HSPA5 | |
| SCHEMBL1140717 | 0.73 | SLC29A1 (0.64) | ADORA3ADORA2ASLC29A1HSPA5AHCY | |
| SCHEMBL9688741 | 0.73 | ADORA2A (0.40) | ADORA3ADORA2AAHCY | |
| SCHEMBL9851725 | 0.72 | SLC29A1 (0.48) | ADORA3ADORA2ASLC29A1AHCYPDE2A | |
| SCHEMBL9851716 | 0.72 | SLC29A1 (0.48) | ADORA3ADORA2ASLC29A1AHCYPDE2A | |
| SCHEMBL15271121 | 0.72 | ADORA2A (0.59) | ADORA3ADORA2ASLC29A1AHCY | |
| SCHEMBL9851786 | 0.71 | ADORA2A (0.46) | ADORA3ADORA2ASLC29A1P2RY12AHCY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0493602-A1 | PROCESS FOR PRODUCING 2',3'-DIDEOXY-2',3'-DIDEHYDRONUCLEOSIDE | YUKI GOSEI KOGYO CO., LTD. (JP) | 1992-07-08 | — | — | EP | disclosed |